Aquestive Therapeutics Inc

NAS:AQSTHealthcareCBOEFTSE:MRUTNASDAQ:NBI

$4.05+5.74%At closeAt close · Wed 21 Oct · ≈ AED 14.87 · Market cap $508.32M · Next earnings Wed 4 Nov · Extended $4.13 +1.98%

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	71.7%	70.5%	59.3%	58.8%	69.0%	61.5%	—	—
Operating margin	−93.6%	−68.2%	−88.2%	−29.9%	−53.5%	−156.4%	−156.4%	+0.0 pts
Net margin	−121.7%	−138.8%	−114.1%	−15.6%	−76.7%	−188.1%	−188.1%	+0.0 pts
EBITDA margin	−85.4%	−88.8%	−83.0%	2.3%	−46.2%	−148.4%	—	—
Return on equity	115.0%	85.9%	45.9%	7.4%	73.4%	248.9%	248.9%	+0.0 pts
Return on assets	−88.7%	−113.8%	−95.3%	−13.7%	−43.5%	−52.2%	−52.2%	+0.0 pts
Return on capital employed	−102.7%	−86.6%	−239.8%	−38.6%	−37.3%	−61.7%	—	—
Debt / equity	−0.8×	−0.7×	−0.5×	−0.3×	−0.6×	−3.9×	−3.9×	+0.0%
Debt / assets	64.4%	91.0%	100.7%	58.0%	37.5%	81.9%	—	—
Interest coverage	−3.3×	−1.5×	−3.4×	−2.0×	−1.8×	−4.1×	—	—
Current ratio	2.1×	2.2×	1.0×	2.2×	4.7×	3.1×	3.1×	+0.0%
Quick ratio	2.0×	2.0×	0.9×	1.9×	4.4×	3.0×	—	—
Cash ratio	1.5×	1.3×	0.7×	1.3×	3.8×	2.5×	2.5×	+0.0%
Asset turnover	0.7×	0.8×	0.8×	0.9×	0.6×	0.3×	—	—
Inventory turnover	5.3×	3.7×	3.4×	3.1×	3.0×	2.8×	—	—
Receivables turnover	6.6×	4.2×	10.1×	6.0×	7.8×	2.5×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—